Showing 2,467 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Neurological & cognitive problems

Delayed treatment of HIV linked to greater risk of dementia

Editor's pick
Kaiser Permanente
26 January 2026
Treatment outcomes & life expectancy

ART Scale-Up Reduces Orphanhood in HIV-Affected Children

Editor's pick
European Medical Journal
26 January 2026
Sexually transmitted infections prevention

ECDC issues guidance on doxycycline for STI prevention

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
26 January 2026
Starting treatment

Early initiation of HIV treatment reduces subsequent risk for cancers unrelated to AIDS

Editor's pick
CATIE
26 January 2026
Injectable & long-acting HIV treatment

Lenacapavir Resistance May Impair HIV Fitness

Editor's pick
POZ
12 January 2026
Treatment outcomes & life expectancy

Dramatic decline in new cases of orphanhood in Uganda driven by HIV treatment and prevention programs

Editor's pick
EurekAlert!
9 January 2026
PrEP science

Event-based PrEP dosing for women: a challenge to guidelines and an activist issue

Editor's pick
i-Base
6 January 2026
Bad science & bogus treatments

Doctors in HIV Cures Controversy at Nakuru Crusade to Face Suspension

Editor's pick
Kenyans.co.ke
5 January 2026
New & experimental HIV treatments

Phase 3 DOR/ISL Shows Promise for HIV Treatment

Editor's pick
Infectious Disease Special Edition
31 December 2025
Transgender people

Lenacapavir PrEP Does Not Interfere With Hormone Therapy for Trans People

Editor's pick
POZ
22 December 2025
New & experimental HIV treatments

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial

Editor's pick
Gilead Sciences press release
16 December 2025
Government, leadership & policy

Top 10 HIV Clinical Developments of 2025

Editor's pick
TheBodyPro
15 December 2025
Sexually transmitted infections prevention

DoxyPEP Use Linked to Increased High-Level Tetracycline Resistance in Neisseria gonorrhoeae

Editor's pick
Contagion Live
26 November 2025
Resistance

New WHO framework aims to tackle rising resistance to HIV, STI, and hepatitis treatments

Editor's pick
CIDRAP
26 November 2025
Resistance

New Data Support Lenacapavir for Treatment-Experienced HIV

Editor's pick
Medscape (requires free registration)
26 November 2025
Treatment guidelines

Interview with Esteban Martinez: EACS Guideline Updates

Editor's pick
European Medical Journal
25 November 2025
New & experimental HIV treatments

Lenacapavir drug resistance in phase 1b study

Editor's pick
i-Base
25 November 2025
New & experimental HIV treatments

Merck's HIV combo matches Gilead's Biktarvy in latest phase 3 test for islatravir

Editor's pick
FierceBiotech
22 November 2025
Starting treatment

Non-AIDS Cancer Risk Drops Considerably When ART Is Initiated Within a Year of HIV Acquisition

Editor's pick
TheBodyPro
22 November 2025
New & experimental HIV treatments

Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings

Editor's pick
FiercePharma
17 November 2025
Cardiovascular disease

Semaglutide Improves Cardiovascular Biomarkers in People With HIV

Editor's pick
POZ
13 November 2025
Drug interactions & pharmacokinetics

No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy

Editor's pick
Contagion Live
3 November 2025
Injectable & long-acting HIV treatment

Gilead ends phase 1 trial after settling on twice-yearly treatment partner for lenacapavir

Editor's pick
FierceBiotech
3 November 2025
New & experimental HIV treatments

IDWeek 2025: Pirmitegravir demonstrates proof of concept in HIV

Editor's pick
Clinical Trials Arena
30 October 2025